查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594436

无针注射系统市场：按技术、产品、可用性、最终用户、应用分类 - 2025-2030 年全球预测

Needle Free Injection System Market by Technology, Product, Usability, End-user, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年无针注射系统市值为225.8亿美元，预计2024年将达253亿美元，复合年增长率为12.11%，预计到2030年将达到502.8亿美元。

无针注射系统是一种创新的药物输送技术，无需使用针头即可给药，最大限度地减少疼痛并提高患者的依从性。此类系统的范围扩展到慢性病管理和免疫计划，为传统注射提供无痛替代方案。对此类系统的需求源于对患者友好且安全的药物输送方法的需求，以减少针刺伤害和针头恐惧症症等风险。此类系统可应用于各个领域，包括医院、诊所和居家医疗，主要最终用途包括糖尿病管理、疫苗接种和生技药品管理。市场成长受到慢性病增加、技术进步以及对微创手术日益偏好等因素的显着影响。然而，同时，这个市场正在应对各种挑战，例如设备成本高、监管障碍以及提供各种药物的技术限制。

主要市场统计
基准年[2023] 225.8亿美元
预测年份 [2024] 253亿美元
预测年份 [2030] 502.8亿美元
复合年增长率（%） 12.11%

机会比比皆是，尤其是在越来越重视医疗保健和最新医疗技术的新兴市场。随着技术创新不断提高送货量并拓宽可输送药物的频谱，预计将进一步成长。市场还可以透过医疗保健提供者和製造商之间的伙伴关係来提高采用率。儘管前景光明，但公司必须投资适合不同製药需求的经济实惠且多功能的系统来应对挑战。加速微注射器和液体喷射器的进步，并将物联网等智慧技术整合到资料主导的健康管理中，可以为创新铺平道路。无针注射器市场的性质正在逐渐发展，其特点是高研究活动和竞争性开发努力，特别是在北美和欧洲等地区。为了取得成功，公司必须跟上监管变化，参与研发，并寻求合作以扩大产品系列和地理覆盖范围。

市场动态：快速发展的无针注射系统市场的关键市场洞察

无针注射系统市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率和传染病发生率增加
    • 生物相似药和疫苗的药物传输需求增加
    • 自动注射器的需求不断增加
  • 市场限制因素
    • 巨大的开发成本和严格的设备法规
  • 市场机会
    • 糖尿病盛行率和报告病例增加
    • 融合先进技术
  • 市场挑战
    • 严格的设备规定

波特五力：驾驭无针注射系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解无针注射系统市场的外部影响

外部宏观环境因素在塑造无针注射系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解无针注射系统市场的竞争状况

对无针注射系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵无针注射系统市场供应商的绩效评估

FPNV定位矩阵是评估无针注射系统市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了无针注射系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对无针注射系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率和感染疾病率增加
      • 对生物相似药和疫苗药物传递的需求增加
      • 自动注射器需求增加
    • 抑制因素
      • 巨大的开发成本和严格的设备法规
    • 机会
      • 糖尿病盛行率和报告病例数不断增加
      • 融合先进技术
    • 任务
      • 与设备相关的严格规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章无针注射系统市场：依技术分类

  • 喷射式无针注射器
  • 雷射驱动无针注射器
  • 弹簧式无针注射器
  • 振动无针注射器

第七章无针注射系统市场：副产品

  • 可填充无针注射器
  • 预填充无针注射器

第八章无针注射系统市场：按可用性

  • 一次性无针注射器
  • 可重复使用的无针注射器

第 9 章 无针注射系统市场：依最终使用者分类

  • 家庭护理设置
  • 医院和诊所
  • 製药和生物技术公司
  • 研究室

第10章无针注射系统市场：依应用

  • 胰岛素给药
  • 肿瘤学
  • 疼痛管理
  • 疫苗

第十一章 美洲无针注射系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区无针注射系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲、中东和非洲无针注射系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aijex Pharma International Inc.
  • Amsino International, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Covestro AG
  • Crossject SA
  • D'Antonio Consultants International, Inc.
  • Endo International PLC
  • European Pharma Group BV
  • Ferring BV
  • Inovio Pharmaceuticals, Inc.
  • Medical International Technology, Inc.
  • PenJet Corporation
  • PharmaJet, Inc.
  • Portal Instruments, Inc.
  • Zogenix, Inc.
Product Code: MRR-FB6C9E792CB8

The Needle Free Injection System Market was valued at USD 22.58 billion in 2023, expected to reach USD 25.30 billion in 2024, and is projected to grow at a CAGR of 12.11%, to USD 50.28 billion by 2030.

The needle-free injection system is a transformative innovation in drug delivery that enables medication administration without needles, thereby minimizing pain and enhancing patient compliance. The scope of these systems encompasses not just chronic disease management but also vaccination programs, offering a pain-free alternative to traditional injections. The necessity for such systems stems from the demand for patient-friendly and safe drug delivery methods, reducing risks such as needle-stick injuries and needle phobia. These systems find application across various sectors including hospitals, clinics, and home care settings, with major end-uses in diabetes management, vaccination, and biologics delivery. Market growth is significantly influenced by factors such as an increase in chronic diseases, technological advancements, and the rising preference for minimally invasive procedures. Concurrently, however, the market grapples with challenges like high device costs, regulatory hurdles, and technical limitations in delivering a broad spectrum of drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 22.58 billion
Estimated Year [2024] USD 25.30 billion
Forecast Year [2030] USD 50.28 billion
CAGR (%) 12.11%

Opportunities abound, particularly in emerging markets where healthcare accessibility and modern medical technologies are increasingly prioritized. Continued innovation in improving delivery volumes and broadening the spectrum of deliverable medications can unlock further growth. The market is also poised to benefit from partnerships between healthcare providers and manufacturers to boost adoption rates. Despite promising prospects, businesses must mitigate challenges by investing in affordable and versatile systems tailored to diverse pharmaceutical needs. Fostering advancements in micro-injectors and liquid jets, and integrating smart technologies such as IoT for data-driven health management can pave the way for innovation. The nature of the needle-free injection market is progressively evolving, characterized by a high degree of research activity and competitive development efforts, particularly in regions like North America and Europe. To thrive, companies should stay abreast of regulatory changes, engage in R&D, and explore collaborations that widen their product portfolios and geographical reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Needle Free Injection System Market

The Needle Free Injection System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic disease and incidence of communicable disease
    • Increasing demand in drug delivery for biosimilars and vaccination
    • Rising demand for self-injection devices
  • Market Restraints
    • Huge development costs, and stringent device regulations
  • Market Opportunities
    • Growing prevalence and reported cases of diabetes
    • Integration of advance technology
  • Market Challenges
    • Stringent regulations associated with devices

Porter's Five Forces: A Strategic Tool for Navigating the Needle Free Injection System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Needle Free Injection System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Needle Free Injection System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Needle Free Injection System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Needle Free Injection System Market

A detailed market share analysis in the Needle Free Injection System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Needle Free Injection System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Needle Free Injection System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Needle Free Injection System Market

A strategic analysis of the Needle Free Injection System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Needle Free Injection System Market, highlighting leading vendors and their innovative profiles. These include Aijex Pharma International Inc., Amsino International, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Covestro AG, Crossject SA, D'Antonio Consultants International, Inc., Endo International PLC, European Pharma Group B.V., Ferring B.V., Inovio Pharmaceuticals, Inc., Medical International Technology, Inc., PenJet Corporation, PharmaJet, Inc., Portal Instruments, Inc., and Zogenix, Inc..

Market Segmentation & Coverage

This research report categorizes the Needle Free Injection System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Jet-Based Needle-Free Injectors, Laser-Powered Needle-Free Injectors, Spring-Based Needle-Free Injectors, and Vibration-Based Needle-Free Injectors.
  • Based on Product, market is studied across Fillable Needle-Free Injectors and Prefilled Needle-Free Injectors.
  • Based on Usability, market is studied across Disposable Needle-Free Injectors and Reusable Needle-Free Injectors.
  • Based on End-user, market is studied across Homecare Settings, Hospitals and Clinics, Pharmaceutical and Biotechnology companies, and Research Laboratories.
  • Based on Application, market is studied across Insulin Delivery, Oncology, Pain Management, and Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic disease and incidence of communicable disease
      • 5.1.1.2. Increasing demand in drug delivery for biosimilars and vaccination
      • 5.1.1.3. Rising demand for self-injection devices
    • 5.1.2. Restraints
      • 5.1.2.1. Huge development costs, and stringent device regulations
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing prevalence and reported cases of diabetes
      • 5.1.3.2. Integration of advance technology
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Needle Free Injection System Market, by Technology

  • 6.1. Introduction
  • 6.2. Jet-Based Needle-Free Injectors
  • 6.3. Laser-Powered Needle-Free Injectors
  • 6.4. Spring-Based Needle-Free Injectors
  • 6.5. Vibration-Based Needle-Free Injectors

7. Needle Free Injection System Market, by Product

  • 7.1. Introduction
  • 7.2. Fillable Needle-Free Injectors
  • 7.3. Prefilled Needle-Free Injectors

8. Needle Free Injection System Market, by Usability

  • 8.1. Introduction
  • 8.2. Disposable Needle-Free Injectors
  • 8.3. Reusable Needle-Free Injectors

9. Needle Free Injection System Market, by End-user

  • 9.1. Introduction
  • 9.2. Homecare Settings
  • 9.3. Hospitals and Clinics
  • 9.4. Pharmaceutical and Biotechnology companies
  • 9.5. Research Laboratories

10. Needle Free Injection System Market, by Application

  • 10.1. Introduction
  • 10.2. Insulin Delivery
  • 10.3. Oncology
  • 10.4. Pain Management
  • 10.5. Vaccine

11. Americas Needle Free Injection System Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Needle Free Injection System Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Needle Free Injection System Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aijex Pharma International Inc.
  • 2. Amsino International, Inc.
  • 3. B. Braun Melsungen AG
  • 4. Baxter International Inc.
  • 5. Becton, Dickinson and Company
  • 6. Covestro AG
  • 7. Crossject SA
  • 8. D'Antonio Consultants International, Inc.
  • 9. Endo International PLC
  • 10. European Pharma Group B.V.
  • 11. Ferring B.V.
  • 12. Inovio Pharmaceuticals, Inc.
  • 13. Medical International Technology, Inc.
  • 14. PenJet Corporation
  • 15. PharmaJet, Inc.
  • 16. Portal Instruments, Inc.
  • 17. Zogenix, Inc.

LIST OF FIGURES

  • FIGURE 1. NEEDLE FREE INJECTION SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. NEEDLE FREE INJECTION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. NEEDLE FREE INJECTION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEEDLE FREE INJECTION SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEEDLE FREE INJECTION SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY JET-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY LASER-POWERED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY SPRING-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VIBRATION-BASED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY FILLABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PREFILLED NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY DISPOSABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY REUSABLE NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM NEEDLE FREE INJECTION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NEEDLE FREE INJECTION SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. NEEDLE FREE INJECTION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023